Holmusk is solving some of the most complex challenges in behavioral health, using AI/ML techniques and our proprietary real-world data. Below is a selection of our conference presentations and peer-reviewed publications.
Categories
Duke Margolis Institute for Health Policy
Operational Tools and Best Practices to Support Electronic Health Record-Sourced Data Quality, Relevance, and Reliability at the Data Accrual Phase
View
,
BMC Medical Informatics and Decision Making
Natural language processing to identify suicidal ideation and anhedonia in major depressive disorder
View
,
Psych Congress
Negative symptoms and cognitive impairment in US patients with schizophrenia: A real-world descriptive study using the NeuroBlu database
View
,
European College of Neuropsychopharmacology
Enhancing mental healthcare through artificial intelligence: A study of depressive disorder symptoms extraction from clinical notes with natural language processing
View
,
European College of Neuropsychopharmacology
Can the evidence for sertraline in clinical trials be demonstrated in real-world clinical practice? A retrospective, observational, real-world study
View
,
European College of Neuropsychopharmacology
Identifying patients with stable schizophrenia using electronic health records
View
,
BMC Psychiatry
Real world analysis of treatment change and response in adults with attention-deficit/hyperactivity disorder (ADHD) alone and with concomitant psychiatric comorbidities: results from an electronic health record database study in the United States
View
,
Journal of Affective Disorders
Healthcare resource utilisation and suicidal ideation amongst adolescents in the US with posttraumatic stress disorder, major depressive disorder, and substance use disorders using electronic health records
View
,
The Journal of Clinical Psychiatry
Learning by Doing: Can Our Collective Experiences as Clinicians Improve Mental Health Care?
View
,
Addiction
Predictability of buprenorphine-naloxone treatment retention: A multi-site analysis combining electronic health records and machine learning
View
,
Duke-Margolis Institute for Health Policy
Real-World Evidence to Support Causal Inference: Methodological Considerations for Non-Interventional Studies
View
,
Duke-Margolis Institute for Health Policy
Regulatory Fit-for-Purpose Considerations for Patient-Generated Health Data
View
,
American Society of Clinical Psychopharmacology
The clinical global impression of severity (CGI-S): Bridging the research-practice gap
View
,
Anxiety and Depression Association of America
Real-world insights into the heterogeneity of treatment patterns and clinical outcomes in patients with post-traumatic stress disorder (PTSD)
View
,
Schizophrenia International Research Society
Clinical characteristics of patients with cognitive impairment associated with schizophrenia
View
,
Schizophrenia International Research Society
Long-term patient functioning and illness burden associated with cognitive impairment and negative symptoms in schizophrenia
View
,
Neuropsychiatric Disease and Treatment
Psychometric evaluation and linking of the PHQ-9, QIDS-C, and VQIDS-C in a real-world population with major depressive disorder
View
,
Natural Language Processing Journal
Enhancing pre-trained contextual embeddings with triplet loss as an effective fine-tuning method for extracting clinical features from electronic health record derived mental health clinical notes
View
,
American Public Health Association
A novel machine learning based model for point-of-care prediction of suicide risk for patients in safety-net healthcare systems
View
,
ISPOR EU
Demographic and clinical factors associated with recurrent psychiatric hospitalizations in adult patients with major depressive disorder (MDD)
View
,
European College of Neuropsychopharmacology Congress
Examining real-world evidence of clinical outcomes, healthcare resource utilisation and treatment patterns of patients with post-traumatic stress disorder
View
,
European College of Neuropsychopharmacology Congress
Examining differences in clinical and demographic characteristics of patients with post-traumatic stress disorder across adults and paediatric subgroups
View
,
European College of Neuropsychopharmacology Congress
Treatment trajectory in people with major depressive disorder from diagnosis to 12 months post-diagnosis
View
,
European College of Neuropsychopharmacology Congress
Treatment trajectory in people with borderline personality disorder from diagnosis to 12 months post-diagnosis
View
,
European College of Neuropsychopharmacology Congress
Clinical characteristics of people with borderline personality disorder at 12 months prior to first diagnosis and at diagnosis
View
,
Therapeutic Advances in Psychopharmacology
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia
View
,
Duke-Margolis Center for Health Policy
Improving Patient Subgroup Representation with Real-World Data
View
,
Schizophrenia Research
Associations of comorbid substance use disorders with clinical outcomes in schizophrenia using electronic health record data
View
,
International Conference on Pharmacoepidemiology
Real-world evidence on the burden of known side-effects of typical and atypical antipsychotic medications in patients with schizophrenia
View
,
American Society of Clinical Psychopharmacology
Elevated anxiety in patients with major depressive disorder
View
,
Schizophrenia International Research Society
Identifying the treatment gap of undiagnosed tardive dyskinesia: an analysis of unstructured electronic health record data
View
,
International Professional Society for Health Economics and Outcomes Research
Investigating trends of behavioral healthcare resource utilization burden in children and adolescents with suicidal symptoms in the United States: An analysis of electronic health record data
View
,
International Professional Society for Health Economics and Outcomes Research
Development of a novel transdiagnostic predictor of psychiatric hospitalization using early trajectories of the Clinical Global Impression Scale
View
,
International Professional Society for Health Economics and Outcomes Research
A comparison of oral aripiprazole with an ingestible sensor to oral atypical antipsychotic treatment in a real-world setting for the risk of hospitalization in adults with schizophrenia
View
,
European Congress of Psychiatry
A real-world data analysis of Clinical Global Impression-Severity (CGI-S) as a transdiagnostic predictor of psychiatric hospitalization
View
,
Academy of Managed Care Pharmacy
Real-world insights into long-acting injectable antipsychotic agent initiation in the inpatient setting and transition/continuation of care: Impact of LAI characteristics on outcomes among patients with schizophrenia
View
,
The Lancet Psychiatry
Early trajectory of clinical global impression as a transdiagnostic predictor of psychiatric hospitalisation: a retrospective cohort study
View
,
Academy of Managed Care Pharmacy
Early clinical instability and increased risk of psychiatric hospitalization: real-world evidence from an analysis of electronic health record data
View
,
ClinicoEconomics and Outcomes Research
Life engagement improvement following initiation of brexpiprazole treatment in patients with MDD: A naturalistic, retrospective real-world study
View
,
Current Medical Research and Opinion
Psychiatric Healthcare Resource Utilization Following Initiation of Aripiprazole Once-Monthly: A Retrospective Real-world Study
View
,
American College of Neuropsychopharmacology
Gender Differences in Adult ADHD Symptoms: Network Analysis of Real-world Data
View
,
National Institute of Health Research MindTech
The impact of a caseload management tool (MaST) on community mental healthcare service delivery
View
,
DGPPN German Association for Psychiatry, Psychotherapy and Psychosomatics
The impact of COVID-19 on psychiatric illness severity and care delivery: A real-world data study
View
,
DGPPN German Association for Psychiatry, Psychotherapy and Psychosomatics
The application of natural language processing to real-world electronic health record data to identify positive and negative symptoms in schizophrenia
View
,
International Professional Society for Health Economics and Outcomes Research: Europe
Transdiagnostic Analysis of Mental Disorder Symptoms Associated with Increased Frequency of Psychiatric Hospitalization
View
,
International Professional Society for Health Economics and Outcomes Research: Europe
Predictors Of Hospitalization In Patients With Newly Diagnosed Major Depressive Disorder: A Real-world Evidence Study
View
,
American Academy of Child & Adolescent Psychiatry
The Impact of Executive Functioning Deficit on Illness Severity in Patients with an ADHD Diagnosis: a Real-world Data Study
View
,
European College of Neuropsychopharmacology
Antipsychotic prescribing trends in schizophrenia between 2011 and 2021: real-world data from a US electronic health record database
View
,
European College of Neuropsychopharmacology
The Association of Comorbid Substance Use Disorders with Time to Treatment Discontinuation in Patients with Schizophrenia
View
,
Academy of Managed Care Pharmacy: Nexus
Antipsychotic Treatment Patterns in Patients with Schizophrenia
View
,
Psych Congress
Psychiatric inpatient healthcare resource utilization and treatment patterns among patients with predominant negative symptoms in schizophrenia
View
,
Psych Congress
A Network Analysis of Borderline Personality Disorder Symptoms: A Real-world Data (RWD), Electronic Health Record (EHR) Study
View
,
Psych Congress
Associations Between Cognitive Symptoms and Poor Clinical Outcomes in Schizophrenia: Real-world Evidence from an Electronic Health Record Study
View
,
European Conference on Mental Health
The Impact of a Caseload Management Tool (MaST) on Community Mental Health Team Care Contacts with Mental Health Service Users
View
,
Royal College of Nursing
Evaluation of the Impact of the Use of a Caseload Management Tool (MaST) in Mersey Care NHS Foundation Trust
View
,
Psychiatric Times
Digital Health as an Enabler for Patient-Centric, Outcome-Based Care
View
,
BJ Psych Open
Derivation and Validation of the Management and Supervision Tool (MaST) Risk of Crisis (RoC) Algorithm Using Electronic Health Record (EHR) Data
View
,
Faculty of Clinical Informatics
A Validation of The Management and Supervision Tool (MaST) to aid NHS mental health teams in identifying patients needs for either psychiatric hospital admission or home treatment
View
,
European Congress of Psychiatry
The Management and Supervision Tool (MaST): An Electronic Crisis Risk Prediction Tool to Support Safe and Effective Mental Healthcare
View
,
European Congress of Psychiatry
NeuroBlu: A Natural Language Processing (NLP) Electronic Health Record (EHR) Data Analytic Tool to Generate Real-world Evidence in Mental Healthcare
View
,
American Society of Clinical Psychopharmacology
Identifying Patients with High Burden of Positive and Negative Schizophrenia Symptoms in Electronic Health Record Data Using Natural Language Processing
View
,
American Society of Clinical Psychopharmacology
Healthcare Resource Use Decreases Following Initiation of Aripiprazole 400mg Long-acting Injectable: A Real-World Electronic Health Record Database Study
View
,
American Society of Clinical Psychopharmacology
Challenges and Opportunities in the Use of Real-world Evidence to Advance Treatment Development in Behavioral Health
View
,
American Psychiatric Association
A Transdiagnostic, Natural Language Processing Analysis of Mental Disorder Symptom Burden Using Electronic Health Record Data
View
,
American Psychiatric Association
Relationship Between Polypharmacy and Clinical Functioning in Patients With ADHD: A Retrospective Analysis of Real World Data
View
,
International Professional Society for Health Economics and Outcomes Research
Illness Severity Associated with Comorbid Substance Use Disorders in Schizophrenia: An Electronic Health Record Study
View
,
international Professional Society for Health Economics and Outcomes Research
How Effective Is Antidepressant Medication (ADM) Polypharmacy in Difficult to Treat Depression (DTD)? a Neuroblu Electronic Health Record (EHR) Report
View
,
Journal of Alzheimer's Disease
Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
View
,
BMJ Open
NeuroBlu, an Electronic Health Record (EHR) Trusted Research Environment (TRE) to Support Mental Healthcare Analytics with Real-world Data
View
,
Schizophrenia International Research Society
Associations of Comorbid Substance Use Disorders with Healthcare Service Utilization: A Cohort Using Electronic Health Record Data
View
,
Schizophrenia International Research Society
Positive and Negative Symptoms in Schizophrenia: A Natural Language Processing Study of Realworld Electronic Health Record Data
View
,
The Journal of Child Psychology and Psychiatry
Editorial: The Gathering Storm: A U.S. Perspective on the Scientific Response to the COVID-19 Child and Adolescent Mental Health Crisis
View
,
PLOS Digital Health
Best Practices in the Real-world Data Life Cycle
View
,
The American Professional Society of ADHD and Related Disorders
Treatment Response and Time to Treatment Discontinuation in Young Children with ADHD: An Analysis of Real-World Data from Electronic Medical Records
View
,
Holmusk Whitepapers
The Need for Real-World Evidence to Close the Behavioral Health Evidence Gap
View
,
American College of Neuropsychopharmacology
Are Symptoms and Functioning Distinct Depression Treatment Targets in the Real World?
View
,
INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH ANNUAL EUROPEAN CONGRESS
Impact of Comorbid Cannabis Use Disorders in Schizophrenia: An Electronic Health Record Real World Data Study
View
,
Psych Congress
Patient life engagement improvements associated with brexpiprazole
View
,
Neuropsychiatric Disease and Treatment
Factors That Affect Patient Attrition in Buprenorphine Treatment for Opioid Use Disorder: A Retrospective Real-World Study Using Electronic Health Records
View
,
American Academy of Child & Adolescent Psychiatry (AACAP) 68th Annual Meeting
Relationship Between Polypharmacy and Clinical Functioning in Patients With ADHD: A Retrospective Analysis of Real-World Data
View
,
Informatics in Medicine Unlocked
A Neural System Dynamics Modeling Platform and its Applications in Randomized Controlled Trial Data Analysis
View
,
American Society of Clinical Psychopharmacology Annual Meeting
Natural Language Processing-Based Quantification of the Mental State of Psychiatric Patients
View
,
American Society of Clinical Psychopharmacology Annual Meeting
NeuroBlu®: A Longitudinal Real-World Evidence Platform for Behavioral Health Research
View
,
American Society of Clinical Psychopharmacology Annual Meeting
Buprenorphine Treatment Retention in Individuals with Opioid Use Disorder: Insights from Real-World Dataset
View
,
The Journal of Child Psychology and Psychiatry
Editorial: Is Child Mental Health Research Structurally Racist?
View
,
Journal of Computational Psychiatry
Natural Language Processing-Based Quantification of the Mental State of Psychiatric Patients
View
,
Holmusk
Generalized Modeling Framework for Disease Progression in Chronic & Mental Health
View
,
International Journal of Bipolar Disorders
The Effects of Vagus Nerve Stimulation on the Course and Outcomes of Patients with Bipolar Disorder in a Treatment-resistant Depressive Episode: a 5-year Prospective Registry
View
,
Holmusk
Digital Therapeutics in Asia - The Key to Managing Healthcare Costs
View
,
Psychiatric Quarterly
Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders
View
,
Psychiatric Services
Use of Augmentation Agents for Treating Depression: Analysis of a Psychiatric Electronic Medical Record Data Set
View
,
Journal of Psychiatric Research
Co-morbid Substance Use Disorders with Other Axis I and II Mental Disorders Among Treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and Mixed-race People
View
,
Journal of Psychiatric Research
Using Electronic Health Records Data to Assess Comorbidities of Substance Use and Psychiatric Diagnoses and Treatment Settings Among Adults
View
,
The Primary Care Companion for CNS Disorders
The Effectiveness of Antidepressant Monotherapy in a Naturalistic Outpatient Setting
View
,
American Journal of Geriatric Psychiatry
Cognitive Improvement Following Treatment in Late Life Depression: Relationship to Vascular Risk and Age of Onset
View
,
Clinical and Translational Science
Patient Electronic Health Data-driven Approach to Clinical Decision Support
View
,
Journal of Biomedical Informatics
VisualDecisionLinc: A Visual Analytics Approach for Comparative Effectiveness-based Clinical Decision Support in Psychiatry
View
,
Journal of Psychiatric Research
Substance Use Disorders and Comorbid Axis I and II Psychiatric Disorders Among Young Psychiatric Patients: Findings from a Large Electronic Health Records Database
View
,
JAMA Psychiatry
Support for the Vascular Depression Hypothesis in Late-Life Depression: Results of a 2-Site, Prospective, Antidepressant Treatment Trial
View
,
Psychosomatics
Prevalence of HIV Infection in a General Psychiatric Outpatient Population
View
,